The Valley Desk

Clinical trial reportEuropean journal of heart failurePublished

Safety and efficacy of aficamten in patients with non-obstructive hypertrophic cardiomyopathy: A 36-week analysis from FOREST-HCM

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
European journal of heart failure
Published
Subject terms
Humans; Cardiomyopathy, Hypertrophic; Natriuretic Peptide, Brain; Stroke Volume; Treatment Outcome; Ventricular Function, Left; Dose-Response Relationship, Drug; Adult; Aged; Middle Aged; Female; Male
PubMed ID
39023326
Added to directory
Source checked

Report a correction or request removal